NCT Number: NCT06522334
The goal of this registry is to systematically record epidemiological and clinical data throughout the whole interstitial lung disease course - starting with the diagnosis, therapy, follow up of lung function, symptom control, adverse events, medication, survival and death.
There are no additional interventions regarding this registry.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Klinik Floridsdorf, Vienna, Austria
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 10 years
Mortality caused by interstitial lung disease
Time frame: 2 years
FVC and DLCO loss within 24 months
Time frame: 10 years
Prevalence of the different interstitial lung diseases in Austria
Time frame: 10 years
Response to immunosuppressive/immunomodulating/antifibrotic drugs
Ludwig Boltzmann Institute for Lung Health
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07613099
Acute Lung Injury, Allogeneic Stem Cell Transplantation
Bethesda, Maryland, United States
View Trial DetailsNCT06325696
Fibrosis, Idiopathic Pulmonary Fibrosis
Research Triangle Park, North Carolina, United States
View Trial DetailsNCT07561034
Cardiovascular Diseases, Hypertension
Rochester, New York, United States
View Trial DetailsNCT07512687
Chronic Disease, Chronic Obstructive Pulmonary Disease
Buffalo, New York, United States
View Trial Details